Zoom and the Trippenhuis, Kloveniersburgwal 29, Amsterdam
Vaccines are able to prevent occurrence of infectious diseases and related morbidity and mortality. The modern mRNA vaccine technology provides great opportunities, since it is rapid, flexible and facilitates a scalable manufacturing process. In addition, these vaccines meet with a relatively good immune response in elderly people.
On March 2022, the Federation of European Academies of Medicine (FEAM) published the report ‘Immunisation for old adults in Europe: scientific and social strategies‘. The document concluded that adult vaccination programmes in Europe often lack prioritisation and funding. It also states that older adults and healthcare workers fail to recognise potential benefits of vaccination for the older population. Vaccine hesitancy is a crucial societal issue that is also addressed. Acceptance and recognition of vaccine benefits is considered key for healthy ageing.
19:00 Part I – The FEAM report highlighted
19:50 Part II – Vaccine hesitancy